Mosaic ImmunoEngineering is a nanotechnology-based immunotherapy company developing therapeutics and vaccines to positively impact the lives of patients and their families.

Free
Message: Has PTSC changed its policy re: Announcements?

In my last conversation with Cliff Flowers, he indicated that PTSC's policy had been to announce news after the close . Today's announcement might indicate a change in that policy.

Perhaps Alliacense is getting the word out that the Markman "appears" to be favorable and the game of "pay this now" or "that later" is once again the strategy for licensees.

Thanks Wings for starting our day with great news.

Share
New Message
Please login to post a reply